MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 05-16-2026
Cerner Corporation Accounts Receivables 2011-2026 | CERN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Cerner Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.16 B | 1.17 B | 1.14 B | 1.18 B | 1.04 B | 945 M | 673 M | - | 583 M | 578 M | 563 M | 461 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.18 B | 461 M | 864 M |
Quarterly Accounts Receivables Cerner Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.18 B | 1.16 B | 1.22 B | 1.24 B | 1.18 B | 1.17 B | 1.22 B | 1.18 B | 1.15 B | 1.14 B | 1.15 B | 1.23 B | 1.16 B | 1.18 B | 1.21 B | 1.15 B | 1.04 B | 1.04 B | 1.02 B | 1.04 B | 986 M | 945 M | 985 M | 983 M | 942 M | 673 M | 1.05 B | 1 B | 941 M | - | 617 M | 615 M | 564 M | 583 M | 529 M | 528 M | 512 M | 578 M | 542 M | 493 M | 536 M | 563 M | 548 M | 504 M | 469 M | 463 M | 442 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.24 B | 442 M | 884 M |
Accounts Receivables of other stocks in the Health information services industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Evolent Health
EVH
|
311 M | $ 3.87 | -2.03 % | $ 442 M |  USA |
 |
Accolade
ACCD
|
9.11 M | - | 0.29 % | $ 206 M | USA |
 |
Change Healthcare
CHNG
|
720 M | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
55 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
480 M | - | - | $ 2.94 B | USA |
 |
HealthEquity
HQY
|
124 M | $ 87.7 | -0.47 % | $ 7.55 B | USA |
 |
iCAD
ICAD
|
7.21 M | - | - | $ 102 M | USA |
 |
GoodRx Holdings
GDRX
|
236 M | $ 2.79 | 5.28 % | $ 994 M | USA |
 |
Akerna Corp.
KERN
|
2.13 M | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
47 M | $ 24.76 | 4.56 % | $ 3.09 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
119 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
15.1 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
137 M | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
77.5 M | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
99.1 M | - | - | $ 2.33 B | USA |
 |
Health Catalyst
HCAT
|
59.1 M | $ 1.25 | -2.71 % | $ 87.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
37.8 M | $ 4.82 | -2.43 % | $ 89.4 M | USA |
 |
Schrödinger
SDGR
|
83 M | $ 13.37 | 0.53 % | $ 982 M | USA |
 |
Phreesia
PHR
|
97.5 M | $ 8.94 | 0.17 % | $ 534 M | USA |
 |
R1 RCM
RCM
|
131 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
193 M | $ 6.66 | 1.37 % | $ 1.17 B | USA |
 |
Signify Health
SGFY
|
156 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
1.58 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
5.95 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
313 K | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
49.7 M | $ 8.28 | 4.02 % | $ 133 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.3 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
32.2 M | $ 23.99 | 0.76 % | $ 720 M | USA |
 |
Omnicell
OMCL
|
217 M | $ 44.42 | 0.02 % | $ 2.04 B | USA |
 |
Progyny
PGNY
|
220 M | $ 25.31 | 1.73 % | $ 2.16 B | USA |
 |
So-Young International
SY
|
51.5 M | $ 1.96 | -12.11 % | $ 153 M |  China |
 |
Veeva Systems
VEEV
|
1.26 B | $ 159.11 | -0.66 % | $ 26 B | USA |
 |
Zhongchao
ZCMD
|
10.3 M | $ 1.43 | - | $ 4.89 M | China |